<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Postadolescent acne in women</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Postadolescent acne in women</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Postadolescent acne in women</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anetta Reszko, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Berson, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cindy Owen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 20, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H68157740"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acne vulgaris is a skin disorder characterized by the presence of comedones and inflammatory lesions on the face, neck, shoulders, or trunk  (<a class="graphic graphic_picture graphicRef98492 graphicRef81177" href="/z/d/graphic/98492.html" rel="external">picture 1A-B</a>). Although the high prevalence of acne in the adolescent population has contributed to a perception that acne is a disorder of youth, acne remains a significant problem for many adults.</p><p>The unique features of postadolescent acne in women will be discussed here. General information on the pathogenesis, clinical features, diagnosis, and management of acne is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris"</a> and  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management"</a> and  <a class="medical medical_review" href="/z/d/html/38.html" rel="external">"Oral isotretinoin therapy for acne vulgaris"</a> and  <a class="medical medical_review" href="/z/d/html/37.html" rel="external">"Light-based, adjunctive, and other therapies for acne vulgaris"</a> and  <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">"Acne vulgaris: Management of moderate to severe acne in adolescents and adults"</a>.)</p><p class="headingAnchor" id="H475461221"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Postadolescent acne is a common disorder that is often defined as acne that occurs in individuals aged 25 years or older. The disorder appears to occur more frequently in women than men [<a href="#rid1">1-8</a>]. As an example, in a population-based study of more than 17,000 individuals in China, acne was more common in men prior to the age of 30 but was more prevalent in women thereafter [<a href="#rid2">2</a>]. Similarly, in a community-based study of 749 adults aged 25 years or older in the United Kingdom, clinically significant acne (defined as Leeds acne grade ≥1) was detected in 12 percent of women but only 3 percent of men [<a href="#rid7">7,9</a>].</p><p>In addition, women may be more likely to visit health care providers for the evaluation and treatment of postadolescent acne [<a href="#rid4">4,10</a>]. In a retrospective study performed in the United Kingdom, 152 out of 200 patients (75 percent) over the age of 25 who were referred to a dermatology department for acne were female [<a href="#rid4">4</a>].</p><p>The prevalence of acne in women steadily decreases with age. This was evident in a prospective study of 2895 women (aged 10 to 70 years) performed in the United States, England, Italy, and Japan [<a href="#rid11">11</a>]. Although acne was most prevalent at age 16 (present in almost 70 percent of subjects) and proceeded to decline after the age of 18, approximately one-half of women in their 20s, one-quarter of women in their 30s, and more than 10 percent of women in their 40s still had clinically significant acne (defined as more than four inflammatory lesions or comedones present on one side of the face). Acne occurred less frequently in postmenopausal women; among women aged 51 years and older, clinically significant acne was detected in less than 5 percent.</p><p class="headingAnchor" id="H159594937"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Similar to acne in other populations, multiple factors contribute to the development of acne lesions in women. The four local events in the skin that are linked to the formation of acne lesions are the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal keratinization of the pilosebaceous follicles </p><p class="bulletIndent1"><span class="glyph">●</span>Excess sebum production </p><p class="bulletIndent1"><span class="glyph">●</span><em>Cutibacterium</em> (formerly <em>Propionibacterium</em>)<em> acnes</em> colonization</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammation</p><p></p><p>Excess sebum production and abnormal follicular keratinization contribute to the formation of comedones, which are considered the primary lesions of acne. Rupture of the comedones and inflammatory reactions to <em>C. acnes</em>, an organism that feeds on sebum, are associated with the development of inflammatory lesions. (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Pathogenesis'</a>.)</p><p>Endogenous or exogenous androgens, the menstrual cycle, smoking, and cosmetic use may contribute to comedone formation in women and may play a role in the development of acne:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Androgens</strong> – Androgens are capable of stimulating the growth of sebaceous glands in the skin and can augment sebum production, characteristics that may contribute to lesion formation [<a href="#rid12">12</a>]. A role for androgens in the development of acne in women is supported by the observation that endogenously or exogenously derived increases in serum androgen levels have been linked to the development of acne [<a href="#rid12">12-15</a>]. In addition, acne in women often improves during treatment with antiandrogenic therapies [<a href="#rid16">16,17</a>]. (See  <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">"Acne vulgaris: Management of moderate to severe acne in adolescents and adults", section on 'Oral hormonal therapies'</a>.)</p><p></p><p class="bulletIndent1">The most common cause of endogenous hyperandrogenemia in women is polycystic ovarian syndrome; less common causes include late-onset adrenal hyperplasia, ovarian hyperthecosis, and virilizing ovarian or adrenal tumors [<a href="#rid17">17,18</a>]. Hyperandrogenemic states may also result from the administration of anabolic steroids or testosterone supplementation. In addition, progestin-only contraceptives that contain proandrogenic progestins and lack antiandrogenic estrogens may contribute to the development of acne [<a href="#rid19">19,20</a>]. (See  <a class="medical medical_review" href="/z/d/html/7436.html" rel="external">"Clinical manifestations of polycystic ovary syndrome in adults"</a> and  <a class="medical medical_review" href="/z/d/html/144.html" rel="external">"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/7397.html" rel="external">"Ovarian hyperthecosis"</a> and  <a class="medical medical_review" href="/z/d/html/16833.html" rel="external">"Sex cord-stromal tumors of the ovary: Epidemiology, clinical features, and diagnosis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/123.html" rel="external">"Adrenal hyperandrogenism"</a>.)</p><p></p><p class="bulletIndent1">However, most adult women with acne have normal androgen levels and do not receive exogenous androgens [<a href="#rid18">18,21</a>]. The relationship between circulating androgen levels and acne in these women is uncertain [<a href="#rid17">17,22</a>]. Proposed mechanisms through which androgens may contribute to acne in these patients include the effects of increased conversion of androgen precursors to androgens within the sebaceous glands and elevated sensitivity of sebaceous glands to androgens [<a href="#rid17">17,23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Menstrual cycle</strong> – Many women with acne note correlation of acne severity with their menstrual cycle. Up to 83 percent of women with acne note premenstrual flares [<a href="#rid3">3,5,24-27</a>]. In one series of 41 women between the ages of 18 and 44 with acne, 63 percent showed a premenstrual increase in the number of inflammatory lesions, and the number of inflammatory lesions present increased by 25 percent [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1">Accumulation of sebum within the sebaceous glands due to a reduction in the size of the pilosebaceous orifice during the premenstrual period has been proposed as a potential contributor to premenstrual flares [<a href="#rid28">28,29</a>]. However, the mechanism responsible for this phenomenon remains unknown.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Smoking</strong> – Several studies have linked smoking to adult female acne, including one study that specifically linked smoking with the presence of noninflammatory acne lesions [<a href="#rid30">30-32</a>]. Effects of nicotine on sebum production or keratinization have been proposed as potential contributing factors [<a href="#rid30">30,31</a>]. Yet, other studies have found conflicting results, and the existence of a causative relationship remains uncertain [<a href="#rid33">33-36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cosmetic products</strong> – The terms "acne cosmetica" and "pomade acne" have been used to describe an association between the use of cosmetic skin or hair products and acne, a phenomenon that was attributed to follicular plugging induced by certain agents [<a href="#rid37">37-39</a>]. This phenomenon may contribute to the insidious, slow development of comedones and, eventually, inflammatory lesions. In addition, follicular irritation related to the application of cosmetics may result in the rapid appearance of an eruption characterized by small, inflammatory papules that closely resembles acne vulgaris (vellus hair folliculitis). (See <a class="local">'Skin care'</a> below and  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent1">The degree to which cosmetic use contributes to acne in the adult female population is unclear [<a href="#rid5">5,22,23,27,40</a>]. The methods used to test comedogenicity of products vary considerably across the cosmetic industry, and products that contain comedogenic ingredients are not necessarily comedogenic when applied to human skin [<a href="#rid40">40,41</a>]. In addition, individual responses to certain products may vary [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other factors</strong> – Other factors that may play a role in acne include stress, diet, and genetic factors [<a href="#rid23">23,26,42</a>]. Data on risk factors specifically for postadolescent acne in women are limited. A case-control study of 248 women with acne and 270 controls found associations between adult female acne and a history of adolescent acne, family history of acne, no prior pregnancies, hirsutism, office work, high level of reported psychologic stress, and low weekly consumption of fruits, vegetables, or fish [<a href="#rid43">43</a>]. Additional studies are required to confirm these findings. (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Diet'</a>.)</p><p></p><p>A more detailed discussion of the pathogenesis of acne is included elsewhere. (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris"</a>.)</p><p class="headingAnchor" id="H159594997"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H2598442548"><span class="h2">Onset</span><span class="headingEndMark"> — </span>Acne in the adult woman may present as a continuation of adolescent acne (persistent acne), which represents the most common presentation, or as a newly developing disorder (late-onset acne) [<a href="#rid4">4,5,7,21,44</a>]. In a prospective study of patients over the age of 25 who presented to a dermatology department in the United Kingdom for acne, only 28 of 152 women (18 percent) had late-onset acne (onset after the age of 25 years) [<a href="#rid4">4</a>]. An international prospective study of 374 adult females (≥25 years of age) who presented to a dermatologist for the evaluation of acne found similar results; only 10 percent of women recalled the onset of acne after age 25 years [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H472182030"><span class="h2">Physical findings</span><span class="headingEndMark"> — </span>As with acne in adolescents, acne in adult women commonly presents with both small, noninflammatory papules (comedones  (<a class="graphic graphic_picture graphicRef62816 graphicRef80536" href="/z/d/graphic/62816.html" rel="external">picture 2A-B</a>)) and inflammatory acne lesions (papules, pustules, or nodules  (<a class="graphic graphic_picture graphicRef98492" href="/z/d/graphic/98492.html" rel="external">picture 1A</a>)). Acne presenting as only noninflammatory or only inflammatory lesions is less common [<a href="#rid21">21</a>]. The face is a common site for involvement, but lesions on the neck and trunk may also occur frequently [<a href="#rid4">4,27</a>]. In the study evaluating acne in 374 adult females with acne, approximately 50 percent of women had truncal involvement [<a href="#rid21">21</a>].</p><p>Some authors have divided facial acne in adult females into two clinical presentations [<a href="#rid5">5,30</a>]. One clinical presentation is characterized by multiple comedones that may be accompanied by a few inflammatory lesions. In this variant, comedones may occur on multiple areas, including the upper face. The other presentation is an inflammatory form characterized by papules, pustules, or nodules that primarily occur on the lower face (eg, chin, perioral skin, and mandible)  (<a class="graphic graphic_picture graphicRef81177 graphicRef98492" href="/z/d/graphic/81177.html" rel="external">picture 1A-B</a>). The reason for this particular distribution is unknown.</p><p>Although lower facial acne has often been viewed as a characteristic presentation of adult female acne  (<a class="graphic graphic_picture graphicRef81177" href="/z/d/graphic/81177.html" rel="external">picture 1B</a>), the findings of the prospective study of 374 adult females with acne described above suggest that lesions limited to this area actually may occur in only a small subset of patients [<a href="#rid21">21</a>]. Only 11 percent of women in the study had lesions limited to the mandibular area.</p><p>The severity of acne in women is typically mild to moderate [<a href="#rid3">3,5,21,30</a>]. It is common for adult patients with inflammatory acne to have only several active lesions at the time of evaluation.</p><p class="headingAnchor" id="H4068437824"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of acne is made based upon the physical examination. Supportive clinical features are comedones and/or inflammatory papules or pustules involving the face, neck, chest, back, and/or shoulders.</p><p class="headingAnchor" id="H2337254815"><span class="h1">ADDITIONAL EVALUATION</span><span class="headingEndMark"> — </span>The evaluation of women with acne should include an assessment for signs of underlying hyperandrogenism and exposure to medications that may cause acne or acneiform eruptions.</p><p class="headingAnchor" id="H1157507728"><span class="h2">Hyperandrogenism</span><span class="headingEndMark"> — </span>Laboratory evaluation for a hyperandrogenic state is indicated in women who exhibit symptoms or signs suggestive of hyperandrogenism [<a href="#rid45">45</a>]. Examples of such features include [<a href="#rid23">23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Signs of virilization, such as hirsutism (male pattern hair growth), frontotemporal hair loss, or clitoromegaly</p><p class="bulletIndent1"><span class="glyph">●</span>Irregular/infrequent menses</p><p class="bulletIndent1"><span class="glyph">●</span>Infertility</p><p class="bulletIndent1"><span class="glyph">●</span>Polycystic ovaries</p><p class="bulletIndent1"><span class="glyph">●</span>Abrupt onset of severe acne</p><p class="bulletIndent1"><span class="glyph">●</span>Acne that is severe or resistant to therapy</p><p class="bulletIndent1"><span class="glyph">●</span>Cushingoid features</p><p class="bulletIndent1"><span class="glyph">●</span>Acanthosis nigricans</p><p class="bulletIndent1"><span class="glyph">●</span>Obesity</p><p></p><p>Of note, since hair removal may make signs of hirsutism undetectable, physical examination is not sufficient for ruling out a hirsute state. Patients should be specifically questioned about male pattern hair growth and hair removal practices. (See  <a class="medical medical_review" href="/z/d/html/7441.html" rel="external">"Evaluation of premenopausal women with hirsutism"</a>.)</p><p>Oral contraceptive agents should be discontinued at least four to six weeks prior to laboratory testing for hyperandrogenism. The laboratory evaluation of patients with acne and suspected hyperandrogenism is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Additional tests'</a>.)</p><p class="headingAnchor" id="H1400240200"><span class="h2">Medications</span><span class="headingEndMark"> — </span>The medication history should be reviewed to identify any medications and supplements that may induce acne or acneiform eruptions  (<a class="graphic graphic_table graphicRef76762" href="/z/d/graphic/76762.html" rel="external">table 1</a>). In particular, progestin-only contraceptive agents, including oral, injected, and implanted agents, have been associated with exacerbation of acne. (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Acneiform eruptions'</a> and  <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">"Acne vulgaris: Management of moderate to severe acne in adolescents and adults", section on 'Oral contraceptives'</a>.) </p><p class="headingAnchor" id="H242120269"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Multiple disorders may present with clinical features that resemble acne vulgaris. In particular, in adult women, the following disorders should be considered:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rosacea </strong>– Rosacea is a common inflammatory disorder that may present with inflammatory papules, pustules, telangiectasias, or erythema involving the central face  (<a class="graphic graphic_picture graphicRef67890" href="/z/d/graphic/67890.html" rel="external">picture 3</a>). The absence of comedones and the centrofacial location of rosacea help to distinguish rosacea from acne. (See  <a class="medical medical_review" href="/z/d/html/13621.html" rel="external">"Rosacea: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Perioral dermatitis </strong>– Perioral dermatitis (also known as periorificial dermatitis) is a disorder most commonly seen in young women that presents with clusters of small papules around the mouth  (<a class="graphic graphic_picture graphicRef73779 graphicRef64577" href="/z/d/graphic/73779.html" rel="external">picture 4A-B</a>). The skin immediately adjacent to the vermilion border of the lip is typically spared. This disorder may also occur in a periocular distribution. (See  <a class="medical medical_review" href="/z/d/html/13622.html" rel="external">"Perioral (periorificial) dermatitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pseudofolliculitis barbae </strong>– Pseudofolliculitis barbae is a condition most commonly seen in Black men that occurs as a result of re-entry of the free ends of short, cut beard hairs into the skin  (<a class="graphic graphic_picture graphicRef51138 graphicRef63934 graphicRef76686" href="/z/d/graphic/51138.html" rel="external">picture 5A-C</a>). Women with terminal hair growth on the face may also develop this condition. (See  <a class="medical medical_review" href="/z/d/html/3323.html" rel="external">"Pseudofolliculitis barbae"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathologic skin picking </strong>– Pathologic skin picking is a behavioral disorder characterized by deliberate and repeated picking or scratching at skin. The term "acne excoriée" has been used to describe patients who repeatedly pick, scratch, or squeeze relatively minor acne lesions, resulting in visible tissue damage that often greatly exceeds the severity of acne  (<a class="graphic graphic_picture graphicRef60854 graphicRef72635 graphicRef66802" href="/z/d/graphic/60854.html" rel="external">picture 6A-C</a>). (See  <a class="medical medical_review" href="/z/d/html/13698.html" rel="external">"Skin picking (excoriation) disorder and related disorders"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug-induced acne (acne medicamentosa)</strong> – Multiple drugs may precipitate acneiform eruptions, including topical or systemic corticosteroids, <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a>, epidermal growth factor inhibitors, and other agents  (<a class="graphic graphic_table graphicRef76762" href="/z/d/graphic/76762.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Acneiform eruptions'</a>.)</p><p></p><p>Other disorders to be considered in the differential diagnosis of postadolescent acne in women include bacterial folliculitis or furunculosis, eosinophilic folliculitis  (<a class="graphic graphic_picture graphicRef54404" href="/z/d/graphic/54404.html" rel="external">picture 7</a>), acne mechanica (development of inflammatory papules at sites of friction or pressure on the skin), and lupus miliaris disseminata faciei  (<a class="graphic graphic_picture graphicRef56241" href="/z/d/graphic/56241.html" rel="external">picture 8</a>). The differential diagnosis of acne vulgaris is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H1633522504"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of acne is not mandatory but is often beneficial for patients for whom acne causes distress, cosmetic concerns, or otherwise negatively impacts quality of life and patients who desire to minimize common sequelae, such as postinflammatory hyperpigmentation and scars  (<a class="graphic graphic_picture graphicRef58817 graphicRef98492" href="/z/d/graphic/58817.html" rel="external">picture 1A, 1C</a>). Even acne that appears mild to the clinician may have significant negative psychosocial effects on the patient [<a href="#rid46">46,47</a>]. </p><p class="headingAnchor" id="H328490533"><span class="h2">Pretreatment assessment</span><span class="headingEndMark"> — </span>As with all patients with acne, assessment of the type of acne lesions present (comedones versus inflammatory lesions), the severity of acne, and the presence of acne sequelae (eg, hyperpigmentation, scarring) is of value for the selection of an appropriate therapeutic regimen. In addition, treatable contributors to acne (eg, hyperandrogenemic states, acne-inducing medications) should be addressed. (See  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management", section on 'Pretreatment assessment'</a>.)</p><p>Considerations that are particularly relevant for postadolescent acne in women include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prior therapies </strong>– Postadolescent acne in women can be difficult to treat, and patient complaints regarding prior ineffective therapies are not uncommon [<a href="#rid4">4</a>]. A history of previous therapeutic interventions should be carefully obtained prior to treatment selection to determine whether specific treatments were truly ineffective. A failure to respond to therapy is sometimes due to a lack of adherence to the treatment regimen for an appropriate amount of time or early discontinuation of an agent due to adverse effects [<a href="#rid48">48</a>]. At least 8 to 12 weeks of consistent treatment is required to judge the effectiveness of many acne medications. (See  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Childbearing status </strong>– Avoidance of many acne therapies is preferable in pregnancy. Women who are candidates for these therapies should be asked about the possibility of existing pregnancy and plans for childbearing in the near future. The results guide appropriate patient counseling and selection of therapy. (See  <a class="medical medical_review" href="/z/d/html/38.html" rel="external">"Oral isotretinoin therapy for acne vulgaris", section on 'Teratogenicity'</a> and  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management", section on 'Pregnant individuals'</a>.)</p><p></p><p class="headingAnchor" id="H1937639452"><span class="h2">Active acne</span><span class="headingEndMark"> — </span>The therapeutic approach to postadolescent acne in women is similar to the approach to acne in other adults and adolescents. In addition to the standard acne therapies available to the general population of acne patients (eg, topical retinoids, <a class="drug drug_general" data-topicid="9038" href="/z/d/drug information/9038.html" rel="external">azelaic acid</a>, salicylic acid, antimicrobial agents, and oral <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">isotretinoin</a>), hormonal therapy is an option for women with acne that can yield clinical improvement even in the absence of hyperandrogenism [<a href="#rid16">16,17</a>]. Oral contraceptives with or without antiandrogenic progestins and <a class="drug drug_general" data-topicid="9943" href="/z/d/drug information/9943.html" rel="external">spironolactone</a> are the most common hormonal therapies prescribed. A more detailed discussion of hormonal therapy in the management of acne is presented separately. (See  <a class="medical medical_review" href="/z/d/html/38.html" rel="external">"Oral isotretinoin therapy for acne vulgaris"</a> and  <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">"Acne vulgaris: Management of moderate to severe acne in adolescents and adults"</a> and  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management"</a>.)</p><p class="headingAnchor" id="H1880273677"><span class="h2">Acne sequelae</span><span class="headingEndMark"> — </span>Features such as postinflammatory hyperpigmentation and scarring may persist long beyond the successful suppression of active lesions and can be highly distressing for patients  (<a class="graphic graphic_picture graphicRef78119 graphicRef58817" href="/z/d/graphic/78119.html" rel="external">picture 1C-D</a>). Thus, interventions that improve these features can be of value and are reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/95847.html" rel="external">"Postinflammatory hyperpigmentation"</a> and  <a class="medical medical_review" href="/z/d/html/90260.html" rel="external">"Management of acne scars"</a> and  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management", section on 'Postinflammatory hyperpigmentation'</a>.)</p><p class="headingAnchor" id="H2750379150"><span class="h1">SKIN CARE</span><span class="headingEndMark"> — </span>Many women also desire advice on skin care regimens. Picking or squeezing lesions, which can increase the risk for scar formation, should be discouraged, and gentle skin cleansing practices are recommended [<a href="#rid49">49</a>]. Many topical acne medications can be particularly irritating in adult skin, and the daily application of moisturizers can limit transepithelial water loss and decrease skin inflammation [<a href="#rid49">49</a>]. Daily sunscreen use is also recommended. (See  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management", section on 'Skin care'</a>.)</p><p>Although the methods for determining comedogenicity in skin care and cosmetic products vary and the importance of cosmetic products as contributors to acne is uncertain [<a href="#rid40">40,41</a>], most dermatologists, including ourselves, continue to favor the use of skin care products (eg, moisturizers, cleansers, cosmetics, etc) labeled as "noncomedogenic" and "nonacnegenic" for patients with acne and suggest the avoidance of occlusive agents. In addition, we advise patients who desire to use foundation as part of their makeup routine to select "oil-free" liquid silicone (<a class="drug drug_general" data-topicid="129549" href="/z/d/drug information/129549.html" rel="external">dimethicone</a> or cyclomethicone) matte foundations over oil-containing products, as the silicone-based products may be less likely to cause follicular occlusion.</p><p class="headingAnchor" id="H416289501"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Although the progressive decrease in the prevalence of acne with increasing age indicates that spontaneous resolution is likely to occur [<a href="#rid11">11</a>], women may suffer from acne for many years. In one survey study of adult women with acne, the mean age of disease onset was 16 years, and patients reported an average duration of acne of 20 years [<a href="#rid26">26</a>].</p><p>The effect of pregnancy on acne vulgaris is variable. Acne may improve, remain unchanged, or worsen during pregnancy [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H3618321066"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114928.html" rel="external">"Society guideline links: Acne vulgaris"</a>.)</p><p class="headingAnchor" id="H328490562"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Acne is a common disorder that affects both adolescents and adults. Although the prevalence of acne vulgaris decreases with age, acne is a significant concern for many adult women. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The factors that contribute to acne in adult women and other populations are similar. Sebum production, keratinization abnormalities, <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>)<em> acnes</em> colonization, and inflammation involving the pilosebaceous follicle contribute to the development of acne vulgaris. (See <a class="local">'Pathogenesis'</a> above and  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Pathogenesis'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although hyperandrogenemia promotes the occurrence of acne vulgaris, many women with acne have normal serum androgen levels. Local production of androgens within the pilosebaceous follicles or an increased sensitivity of sebaceous glands to tissue androgens may contribute to acne in these women. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Many women with postadolescent acne experience premenstrual flares. The reason for this observation is unknown. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postadolescent acne most commonly occurs as a consequence of the persistence of adolescent acne. Women often present with both inflammatory and noninflammatory acne lesions. A subset of women with acne may present with lesions primarily distributed on the lower face  (<a class="graphic graphic_picture graphicRef81177" href="/z/d/graphic/81177.html" rel="external">picture 1B</a>). (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The possibility of a hyperandrogenemic state should be considered in women who present with acne. If signs or symptoms of hyperandrogenism are present, laboratory evaluation is indicated. (See <a class="local">'Hyperandrogenism'</a> above and  <a class="medical medical_review" href="/z/d/html/39.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Acneiform eruptions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The treatment of adult women with acne involves a review of prior therapies, assessment of lesion types, and the evaluation for conditions that may influence the selection of therapy. Topical retinoids, antimicrobial agents, and hormonal drugs are often used for the management of acne. Gentle skin care practices are also recommended. (See <a class="local">'Treatment'</a> above and  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Yentzer BA, Hick J, Reese EL, et al. Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010; 86:94.</a></li><li><a class="nounderline abstract_t">Shen Y, Wang T, Zhou C, et al. Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities. Acta Derm Venereol 2012; 92:40.</a></li><li><a class="nounderline abstract_t">Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15:541.</a></li><li><a class="nounderline abstract_t">Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997; 136:66.</a></li><li><a class="nounderline abstract_t">Preneau S, Dreno B. Female acne - a different subtype of teenager acne? J Eur Acad Dermatol Venereol 2012; 26:277.</a></li><li><a class="nounderline abstract_t">Seirafi H, Farnaghi F, Vasheghani-Farahani A, et al. Assessment of androgens in women with adult-onset acne. Int J Dermatol 2007; 46:1188.</a></li><li><a class="nounderline abstract_t">Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol 1999; 41:577.</a></li><li><a class="nounderline abstract_t">Skroza N, Tolino E, Mambrin A, et al. Adult Acne Versus Adolescent Acne: A Retrospective Study of 1,167 Patients. J Clin Aesthet Dermatol 2018; 11:21.</a></li><li><a class="nounderline abstract_t">Burke BM, Cunliffe WJ. The assessment of acne vulgaris--the Leeds technique. Br J Dermatol 1984; 111:83.</a></li><li><a class="nounderline abstract_t">Kane A, Niang SO, Diagne AC, et al. Epidemiologic, clinical, and therapeutic features of acne in Dakar, Senegal. Int J Dermatol 2007; 46 Suppl 1:36.</a></li><li><a class="nounderline abstract_t">Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris in women: prevalence across the life span. J Womens Health (Larchmt) 2012; 21:223.</a></li><li><a class="nounderline abstract_t">Yildiz BO. Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 2006; 20:167.</a></li><li><a class="nounderline abstract_t">Timpatanapong P, Rojanasakul A. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. J Dermatol 1997; 24:223.</a></li><li><a class="nounderline abstract_t">Skampardonis N, Kouskoukis A, Karpouzis A, Maroulis G. Marked hyperandrogenemia and acne associated with polycystic ovaries in Greek women with polycystic ovary syndrome. Clin Exp Obstet Gynecol 2011; 38:168.</a></li><li><a class="nounderline abstract_t">Chen W, Obermayer-Pietsch B, Hong JB, et al. Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol 2011; 25:637.</a></li><li><a class="nounderline abstract_t">George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg 2008; 27:188.</a></li><li><a class="nounderline abstract_t">Shaw JC. Acne: effect of hormones on pathogenesis and management. Am J Clin Dermatol 2002; 3:571.</a></li><li><a class="nounderline abstract_t">Arora MK, Seth S, Dayal S. The relationship of lipid profile and menstrual cycle with acne vulgaris. Clin Biochem 2010; 43:1415.</a></li><li><a class="nounderline abstract_t">Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49:S1.</a></li><li><a class="nounderline abstract_t">Grossman Barr N. Managing adverse effects of hormonal contraceptives. Am Fam Physician 2010; 82:1499.</a></li><li><a class="nounderline abstract_t">Dréno B, Thiboutot D, Layton AM, et al. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol 2015; 29:1096.</a></li><li><a class="nounderline abstract_t">Knaggs HE, Wood EJ, Rizer RL, Mills OH. Post-adolescent acne. Int J Cosmet Sci 2004; 26:129.</a></li><li><a class="nounderline abstract_t">Williams C, Layton AM. Persistent acne in women : implications for the patient and for therapy. Am J Clin Dermatol 2006; 7:281.</a></li><li><a class="nounderline abstract_t">Lucky AW. Quantitative documentation of a premenstrual flare of facial acne in adult women. Arch Dermatol 2004; 140:423.</a></li><li><a class="nounderline abstract_t">Stoll S, Shalita AR, Webster GF, et al. The effect of the menstrual cycle on acne. J Am Acad Dermatol 2001; 45:957.</a></li><li><a class="nounderline abstract_t">Shaw JC, White LE. Persistent acne in adult women. Arch Dermatol 2001; 137:1252.</a></li><li><a class="nounderline abstract_t">Addor FA, Schalka S. Acne in adult women: epidemiological, diagnostic and therapeutic aspects. An Bras Dermatol 2010; 85:789.</a></li><li><a class="nounderline abstract_t">Burton JL, Cartlidge M, Shuster S. Variations in sebum excretion during the menstrual cycle. Acta Derm Venereol 1973; 53:81.</a></li><li><a class="nounderline abstract_t">Williams M, Cunliffe WJ. Explanation for premenstrual acne. Lancet 1973; 2:1055.</a></li><li><a class="nounderline abstract_t">Capitanio B, Sinagra JL, Bordignon V, et al. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol 2010; 63:782.</a></li><li><a class="nounderline abstract_t">Capitanio B, Sinagra JL, Ottaviani M, et al. Acne and smoking. Dermatoendocrinol 2009; 1:129.</a></li><li><a class="nounderline abstract_t">Schäfer T, Nienhaus A, Vieluf D, et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145:100.</a></li><li><a class="nounderline abstract_t">Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 2009; 129:2136.</a></li><li><a class="nounderline abstract_t">Mills CM, Peters TJ, Finlay AY. Does smoking influence acne? Clin Exp Dermatol 1993; 18:100.</a></li><li><a class="nounderline abstract_t">Klaz I, Kochba I, Shohat T, et al. Severe acne vulgaris and tobacco smoking in young men. J Invest Dermatol 2006; 126:1749.</a></li><li><a class="nounderline abstract_t">Rombouts S, Nijsten T, Lambert J. Cigarette smoking and acne in adolescents: results from a cross-sectional study. J Eur Acad Dermatol Venereol 2007; 21:326.</a></li><li><a class="nounderline abstract_t">Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46:S98.</a></li><li><a class="nounderline abstract_t">Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch Dermatol 1970; 101:580.</a></li><li><a class="nounderline abstract_t">Kligman AM, Mills OH Jr. "Acne cosmetica". Arch Dermatol 1972; 106:843.</a></li><li><a class="nounderline abstract_t">Draelos ZD, DiNardo JC. A re-evaluation of the comedogenicity concept. J Am Acad Dermatol 2006; 54:507.</a></li><li><a class="nounderline abstract_t">Maarouf M, Saberian C, Shi VY. Myths, Truths, and Clinical Relevance of Comedogenicity Product Labeling. JAMA Dermatol 2018; 154:1131.</a></li><li><a class="nounderline abstract_t">Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141:297.</a></li><li><a class="nounderline abstract_t">Di Landro A, Cazzaniga S, Cusano F, et al. Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy. J Am Acad Dermatol 2016; 75:1134.</a></li><li><a class="nounderline abstract_t">Marks R. Acne and its management beyond the age of 35 years. Am J Clin Dermatol 2004; 5:459.</a></li><li><a class="nounderline abstract_t">Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74:945.</a></li><li><a class="nounderline abstract_t">Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134:454.</a></li><li><a class="nounderline abstract_t">Demircay Z, Seckin D, Senol A, Demir F. Patient's perspective: an important issue not to be overlooked in assessing acne severity. Eur J Dermatol 2008; 18:181.</a></li><li><a class="nounderline abstract_t">Dréno B, Thiboutot D, Gollnick H, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol 2010; 49:448.</a></li><li><a class="nounderline abstract_t">Goodman G. Cleansing and moisturizing in acne patients. Am J Clin Dermatol 2009; 10 Suppl 1:1.</a></li></ol></div><div id="topicVersionRevision">Topic 13615 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20919604" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acne vulgaris in the United States: a descriptive epidemiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21710106" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11843213" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : An epidemiological study of acne in female adults: results of a survey conducted in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9039297" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Post-adolescent acne: a review of clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21848892" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Female acne - a different subtype of teenager acne?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17988341" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Assessment of androgens in women with adult-onset acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10495379" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prevalence of facial acne in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29410726" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Adult Acne Versus Adolescent Acne: A Retrospective Study of 1,167 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6234917" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The assessment of acne vulgaris--the Leeds technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17919205" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Epidemiologic, clinical, and therapeutic features of acne in Dakar, Senegal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22171979" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Acne vulgaris in women: prevalence across the life span.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16772149" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Diagnosis of hyperandrogenism: clinical criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9164062" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21793282" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Marked hyperandrogenemia and acne associated with polycystic ovaries in Greek women with polycystic ovary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21198949" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Acne-associated syndromes: models for better understanding of acne pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18786497" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hormonal therapy for acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12358558" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acne: effect of hormones on pathogenesis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20880492" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The relationship of lipid profile and menstrual cycle with acne vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12833004" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21166370" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Managing adverse effects of hormonal contraceptives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25296739" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Large-scale international study enhances understanding of an emerging acne population: adult females.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18494869" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Post-adolescent acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17007539" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Persistent acne in women : implications for the patient and for therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15096370" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Quantitative documentation of a premenstrual flare of facial acne in adult women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11712049" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The effect of the menstrual cycle on acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11559234" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Persistent acne in adult women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21308301" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acne in adult women: epidemiological, diagnostic and therapeutic aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4120962" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Variations in sebum excretion during the menstrual cycle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4127313" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Explanation for premenstrual acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20619486" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Underestimated clinical features of postadolescent acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20436880" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Acne and smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11453915" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Epidemiology of acne in the general population: the risk of smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19282841" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8481981" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Does smoking influence acne?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16645586" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Severe acne vulgaris and tobacco smoking in young men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17309453" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cigarette smoking and acne in adolescents: results from a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11807471" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acne vulgaris in skin of color.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4245751" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pomade acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4264346" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : "Acne cosmetica".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16488305" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A re-evaluation of the comedogenicity concept.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29998304" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Myths, Truths, and Clinical Relevance of Comedogenicity Product Labeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10468803" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27542588" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15663343" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Acne and its management beyond the age of 35 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26897386" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Guidelines of care for the management of acne vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9554297" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Acne vulgaris and the quality of life of adult dermatology patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18424379" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Patient's perspective: an important issue not to be overlooked in assessing acne severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20465705" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Large-scale worldwide observational study of adherence with acne therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19209947" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Cleansing and moisturizing in acne patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
